Immunohistochemical and fluorescence in situ hybridization studies on noninvasive and invasive extramammary Paget's disease

International Journal of Surgical Pathology

Volumn 20, Issue 5, 2012, Pages 441-448

  Hikita, Tomonori ^a   Ohtsuki, Yuji ^b   Maeda, Toshiharu ^c   Furihata, Mutsuo ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b MATSUYAMA SHIMIN HOSPITAL   (Japan)

^c EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

CK19; extramammary Paget's disease; fluorescence in situ hybridization (FISH); HER 2; immunohistochemistry

Indexed keywords

CYTOKERATIN 19; CYTOKERATIN 7; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MUCIN 1; PROTEIN CAM5.2; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PAGET SKIN DISEASE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CELL NUCLEUS; FEMALE; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KERATIN-19; KERATIN-7; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PAGET DISEASE, EXTRAMAMMARY; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84866685596     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896912444159     Document Type: Article

References (25)

1. Ordonetz NG, Awalt H, Mackay B. Mammary and extramammary Paget's disease: an immunocytochemical and ultrastructural study. Cancer. 1987 ; 59: 1173-1183
2. Ganjei P, Giraldo KA, Lampe B, Nadji M. Vulvar Paget's disease. Is immunohistochemistry helpful in assessing the surgical margins?. J Reprod Med. 1990 ; 35: 1002-1005
3. Liegl B, Leibl S, Gogg-Kamerer M, Tessaro B, Horn LC, Moinfar F. Mammary and extramammary Paget's disease: an immunohistochemical study of 83 cases. Histopathology. 2007 ; 50: 439-447
4. Thway K, Polson A, Pope R, Thomas JM, Fisher C. Extramammary Paget disease in a retrorectal dermoid cyst: report of a unique case. Am J Surg Pathol. 2008 ; 32: 635-639
5. Yoshii N, Yonezawa S, Matsukita S, Matsukita S, Setoyama M, Kanzaki T. Expression of mucin core proteins in extramammary Paget's disease. Pathol Int. 2002 ; 52: 390-399
6. Mori O, Hachisuka H, Nakano S, Sasai Y, Shiku H. Expression of ras p21 in mammary and extramammary Paget's disease. Arch Pathol Lab Med. 1990 ; 114: 858-861
7. Nakamura G, Shikata N, Shoji T, Hatano T, Hioki K, Tsubura A. Immunohistochemical study of mammary and extramammary Paget's disease. Anticancer Res. 1995 ; 15: 467-470
8. Yanai H, Takahashi N, Omori M, et al. Immunohistochemistry of p63 in primary and secondary vulvar Paget's disease. Pathol Int. 2008 ; 58: 648-651
9. Chen S, Moroi Y, Urabe K, et al. Differential expression of two new members of the p53 family, p63 and p73, in extramammary Paget's disease. Clin Exp Dermatol. 2008 ; 33: 634-640
10. Xie LN, Hayashide S, Kido M, et al. Stromal CD10 expression is correlated with invasiveness and proliferation of extramammary Paget disease. Br J Dermatol. 2008 ; 158: 1389-1391
11. Aoyagi S, Akiyama M, Shimizu H. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget's disease. J Dermatol Sci. 2008 ; 50: 177-184
12. Ellis PE, Maclean AB, Crow JC, Wong Te, Fong LF, Rolfe KJ, Perrett CW. Expression of cyclin D1 and retinoblastoma protein in Paget's disease of the vulva and breast: an immunohistochemical study of 108 cases. Histopathology. 2009 ; 55: 709-715
13. Imam A, Yoshida SO, Taylor CR. Distinguishing tumour cells of mammary from extramammary Paget's disease using antibodies to two different glycoproteins from human milk-fat-globule membrane. Br J Cancer. 1988 ; 58: 373-378
14. Regauer S. Extramammary Paget's disease-a proliferation of adnexal origin?. Histopathology. 2006 ; 48: 723-729
15. Keatings L, Sinclair J, Wright C, et al. c-erbB-2 oncoprotein expression in mammary and extramammary Paget's disease: an immunohistochemical study. Histopathology. 1990 ; 17: 243-247
16. Nishi M, Yoshida H, Setoyama M, Tashiro M. Immunohistochemical study of c-erbB-2 oncoprotein expression in extramammary Paget's disease. Dermatology. 1994 ; 188: 100-102
17. Takata M, Fujimoto A, Aoki H, Hatta N, Ooi A, Takehara K. erbB-2 overexpression but no activation of beta-Catenin gene in extramammary Paget's disease. J Invest Dermatol. 1999 ; 113: 258-262
18. Plaza JA, Torres-Cabala C, Ivan D, Prieto VG. HER-2/neu expression in extramammary Paget disease: a clinicopathologic and immunohistochemistry study of 47 cases with and without underlying malignancy. J Cutan Pathol. 2009 ; 36: 729-733
19. Ogawa T, Nagashima Y, Wada H, et al. Extramammary Paget's disease: analysis of growth signal pathway from the human epidermal growth factor receptor 2 protein. Hum Pathol. 2005 ; 36: 1273-1280
20. Tanskanen M, Jahkola T, Asko-Seljavaara S, Jalkanen J, Isola J. HER2 oncogene amplification in extramammary Paget's disease. Histopathology. 2003 ; 42: 575-579
21. Ohtsuki Y, Fujita J, Hachisuka Y, et al. Immunohistochemical and immunoelectron microscopic studies of the localization of KL-6 and epithelial membrane antigen (EMA) in presumably normal pulmonary tissue and interstitial pneumonia. Med Mol Morphol. 2007 ; 40: 198-202
22. Ohtsuki Y, Nakanishi N, Fujita J, et al. Immunohistochemical distribution of SP-D, compared with those of SP-A and KL-6 in interstitial pneumonias. Med Mol Morphol. 2007 ; 40: 163-167
23. Tsuda H, Akiyama F, Terasaki H, et al. Detection of HER-2/neu(c-erb B-2)DNA amplification in primary breast carcinoma. Interobserver reproducibility and correlation with immunohistochemical HER-2 overexpression. Cancer. 2001 ; 92: 2965-2974
24. Dowsett M, Bartlett J, Ellis IO, et al. Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 32 centres. J Pathol. 2003 ; 199: 418-423
25. Press MF, Sauter G, Bernstein L, et al. Diagnostic elevation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials. Clin Cancer Res. 2005 ; 11: 6598-6607